These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1340115

  • 1. Antisense strategies to characterize the role of genes and oncogenes involved in myeloid differentiation.
    Ferrari S, Manfredini R, Grande A, Torelli U.
    Ann N Y Acad Sci; 1992 Oct 28; 660():11-26. PubMed ID: 1340115
    [No Abstract] [Full Text] [Related]

  • 2. Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification.
    Smithgall TE, Johnston JB, Bustin M, Glazer RI.
    J Natl Cancer Inst; 1991 Jan 02; 83(1):42-6. PubMed ID: 1984516
    [Abstract] [Full Text] [Related]

  • 3. Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation.
    Ferrari S, Manfredini R, Tagliafico E, Grande A, Barbieri D, Balestri R, Pizzanelli M, Zucchini P, Citro G, Zupi G.
    Leukemia; 1994 Apr 02; 8 Suppl 1():S91-4. PubMed ID: 8152313
    [Abstract] [Full Text] [Related]

  • 4. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells.
    Manfredini R, Balestri R, Tagliafico E, Trevisan F, Pizzanelli M, Grande A, Barbieri D, Zucchini P, Citro G, Franceschi C, Ferrari S.
    Blood; 1997 Jan 01; 89(1):135-45. PubMed ID: 8978286
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.
    Manfredini R, Grande A, Tagliafico E, Barbieri D, Zucchini P, Citro G, Zupi G, Franceschi C, Torelli U, Ferrari S.
    J Exp Med; 1993 Aug 01; 178(2):381-9. PubMed ID: 8340750
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
    Ferrari S, Donelli A, Manfredini R, Sarti M, Roncaglia R, Tagliafico E, Rossi E, Torelli G, Torelli U.
    Cell Growth Differ; 1990 Nov 01; 1(11):543-8. PubMed ID: 2088479
    [Abstract] [Full Text] [Related]

  • 7. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
    Yu G, Smithgall TE, Glazer RI.
    J Biol Chem; 1989 Jun 15; 264(17):10276-81. PubMed ID: 2656706
    [Abstract] [Full Text] [Related]

  • 8. Expression pattern of c-fes oncogene mRNA in human myeloid cells.
    Lanfrancone L, Mannoni P, Pebusque MJ, Carè A, Peschle C, Grignani F, Pelicci PG.
    Int J Cancer Suppl; 1989 Jun 15; 4():35-8. PubMed ID: 2681011
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines.
    Jücker M, Schaadt M, Diehl V, Poppema S, Jones D, Tesch H.
    Hematol Oncol; 1990 Jun 15; 8(4):191-204. PubMed ID: 2210688
    [Abstract] [Full Text] [Related]

  • 10. Effect of the mutation of tyrosine 713 in p93c-fes on its catalytic activity and ability to promote myeloid differentiation in K562 cells.
    Fang F, Ahmad S, Lei J, Klecker RW, Trepel JB, Smithgall TE, Glazer RI.
    Biochemistry; 1993 Jul 13; 32(27):6995-7001. PubMed ID: 8334128
    [Abstract] [Full Text] [Related]

  • 11. An insertion deletion polymorphism associated with C-FES.
    Bowden DW, Akots G, Rothschild CB.
    Nucleic Acids Res; 1991 Aug 11; 19(15):4311. PubMed ID: 1870997
    [No Abstract] [Full Text] [Related]

  • 12. HIV-TAR homology with human c-fes oncogene.
    Chirmule N, Pahwa S.
    Life Sci; 1994 Aug 11; 54(18):PL313-4. PubMed ID: 8189999
    [No Abstract] [Full Text] [Related]

  • 13. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA, Hoffman-Liebermann B.
    Oncogene; 1989 May 11; 4(5):583-92. PubMed ID: 2471131
    [Abstract] [Full Text] [Related]

  • 14. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
    Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW.
    Proc Natl Acad Sci U S A; 1993 Apr 15; 90(8):3516-20. PubMed ID: 7682708
    [Abstract] [Full Text] [Related]

  • 15. Expression of the c-fes proto-oncogene in granulocyte-macrophage colony-stimulating factor-dependent acute myelogenous leukemia cells grown autonomously.
    Brach MA, Gauer E, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F.
    Int J Cell Cloning; 1991 Jan 15; 9(1):89-94. PubMed ID: 2010659
    [Abstract] [Full Text] [Related]

  • 16. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA, Hoffman B.
    Stem Cells; 1994 Jul 15; 12(4):352-69. PubMed ID: 7951003
    [Abstract] [Full Text] [Related]

  • 17. Polymorphism at the FES locus detected by PFGE.
    Koch K, Jücker M, Michels M, van de Ven WJ, Tesch H.
    Nucleic Acids Res; 1990 Oct 11; 18(19):5918. PubMed ID: 1977140
    [No Abstract] [Full Text] [Related]

  • 18. The c-abl oncogene in chronic myelogenous leukemia.
    de Klein A, Bartram CR, Hagemeijer A, Heisterkamp N, Stam K, Groffen J, Grosveld G.
    Haematologica; 1987 Oct 11; 72(6 Suppl):19-22. PubMed ID: 3127291
    [No Abstract] [Full Text] [Related]

  • 19. Molecular biology of chronic myelogenous leukemia.
    Dreazen O, Canaani E, Gale RP.
    Semin Hematol; 1988 Jan 11; 25(1):35-48. PubMed ID: 3279514
    [Abstract] [Full Text] [Related]

  • 20. The human tyrosine kinase gene (FER) maps to chromosome 5 and is deleted in myeloid leukemias with a del(5q).
    Morris C, Heisterkamp N, Hao QL, Testa JR, Groffen J.
    Cytogenet Cell Genet; 1990 Jan 11; 53(4):196-200. PubMed ID: 2209086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.